A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD)(ROCKET-ASCEND)
Clinical Trial Grant
Administered By
Dermatology
Awarded By
Amgen, Inc.
Start Date
December 15, 2023
End Date
February 1, 2028
Administered By
Dermatology
Awarded By
Amgen, Inc.
Start Date
December 15, 2023
End Date
February 1, 2028